Novartis | 自己資本および準備金



Equity Capital And Reserves 変化する 日付
AbbVie USD 3.32B 2.71B 2024-12
Alcon AG USD 21.55B 164M 2024-12
Almirall EUR 1.49B 10.37M 2024-06
Amgen USD 5.88B 1.65B 2024-12
AstraZeneca USD 40.87B 66M 2024-12
Autolus Therapeutics Ltd 476.96M 50.88M 2024-09
Bayer EUR 32.04B 1.49B 2024-12
Biogen USD 16.72B 357.1M 2024-12
Bristol-Myers Squibb USD 16.34B 807M 2024-12
Eli Lilly USD 14.19B 47.9M 2024-12
Fresenius EUR 19.54B 715M 2024-12
Fresenius Medical Care EUR 14.58B 214.44M 2024-12
Galapagos EUR 2.9B 34.37M 2024-12
Genmab DKK 36.7B 4.78B 2024-12
Gilead Sciences USD 19.33B 856M 2024-12
GlaxoSmithKline GBP 13.67B 218M 2024-12
GRIFOLS EUR 5.88B 533.83M 2024-12
Hikma Pharmaceutical USD 2.29B 88M 2024-06
J&J USD 71.49B 1.33B 2024-12
Lonza CHF 9.33B 23M 2024-12
Merck EUR 28.32B 226M 2024-09
Merck USD 46.31B 1.81B 2024-12
Novartis USD 44.05B 605M 2024-12
Novartis USD 44.05B 729M 2024-12
Novo Nordisk 120.52B 8B 2024-09
Orion EUR 1.01B 80.6M 2024-12
Pfizer USD 88.2B 4.08B 2024-12
Philips EUR 12.01B 87M 2024-12
Recordati EUR 1.88B 694K 2024-12
Regeneron Pharmaceuticals USD 29.35B 27.7M 2024-12
Roche Holding CHF 36.16B 3.28B 2024-12
Sanofi 73B 1.36B 2024-06
UCB EUR 10.03B 1.08B 2024-12



Novartis 自己資本および準備金 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - Mar 2025.